SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explained that SGD Pharma intends to significantly grow in 2024.
Underpinning this objective, Rousseau outlined the investment achievements already notched up in 2023, to illustrate how SGD Pharma has paved the way for this planned growth.
“The start of 2023 brought a new partnership, with the announcement of our joint venture with Corning, supported by investment from the Telangana state in India. This collaboration combined Corning’s state-of-the-art coating technology with SGD Pharma’s glass-converting expertise to manufacture Velocity Vials, Type I borosilicate glass tubing.”
The construction of a new tubing plant officially began with a celebratory ground-breaking ceremony at the plant in Vemula, India in June 2023. On completion, this new facility will expand pharmaceutical packaging manufacturing in India and access to the Corning Velocity Vial technology in the region.
Another key area of progress for SGD Pharma last year was the company’s sustainable efforts and decarbonization strategy. SGD Pharma was awarded a gold EcoVadis sustainability rating and made a number of modifications throughout the year to improve its high score for the 2023 award.
As well as the new line for Vemula, India, other site investments include the renovation of one of two furnaces at SGD Pharma’s Saint Quentin Lamotte (SQLM) plant in France.
Furthermore, a Memorandum of Understanding was signed with the Mayor of Zhanjiang in China for SGD Pharma to invest in the rebuilding of the plant furnace at Zhanjiang and a new siliconization operation line will become operational at the SQLM plant to increase flexibility and capacity.
In terms of products, SGD Pharma launched the extension of its Clareo range to include 10ml as well as its Sterinity range of ready-to-use vials in sizes 10ml and 20ml. The second half of the year saw the announcement of the company’s pharmaceutical vial thermosealing offering, PROSEAL+.
Additionally, SGD Pharma celebrated 30 years in China at its Zhanjiang manufacturing plant, which produces moulded glass and is market leader in glass for cosmetics and beauty packaging.
To round up the investments in 2023, SGD Pharma CEO Olivier Rousseau is looking ahead to a number of strategic developments for 2024, which will start with announcements at Pharmapack 2024 in booth B60/B62.